A patient has published a blog documenting her time on INTERLACE, a clinical trial for the treatment of cervical cancer run by the CRUK & UCL Cancer Trials Centre.
The patient, aged 31 at the time, underwent treatment in 2015 having been diagnosed in April of the same year.
Explaining her reasons for starting the blog, the patient states: ‘As I went through this disease, with my normal activity limited, I began writing in order to digest the load of information mentally’.
Around 3,200 women in the UK are diagnosed with cervical cancer each year, with more than half of this number aged 45 or under. INTERLACE investigates the potential benefits of 6 weeks of additional chemotherapy for these patients, a course given prior to the standard cervical cancer treatment of combined chemotherapy and radiotherapy.
From experiencing her first symptoms and explaining her decision enter the trial, through to her treatment visits and the eventual remission of the disease, the blog provides a detailed insight into the patient’s day-to-day thoughts, actions and feelings following diagnosis.
You can read the full blog
here.
INTERLACE remains open to patients at sites across the UK and abroad. More details about the study can be found
here.